Tue, Jul 22, 2014, 10:53 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Forest Laboratories Inc. Message Board

  • spaceout747 spaceout747 Jan 13, 2013 2:42 PM Flag

    More Ugrades for FRX

    Finally Goldman Sachs Upgraded FRX , prior to this several others have , Cantor Fitzgerald Reaffirms Buy Rating $48.00.. Citigroup issued a buy rating .. Cowen upgraded to Outperform..so we can expect all the other sheep to follow. Carl Icahn still on board.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Upgrades? FRX business is down over 30% due to Lexapro patent expiration, and profits are down 90%. Future products not likely to make up for Lexapro any time soon. Obamacare will likely suppress all drug prices. So, what price for FRX making fifty cents per year? FRX will see $25 this year, seems to me. The upgrades are classic Walls Street manipulations. Sell now, as the FRX business does not support the current stock price. FRX might go closer to $10 over the next two years as the pipeline is unlikely to make up for Lexapro anytime soon IMHO.

      Sentiment: Strong Sell

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.